Hologic Inc. (HOLX) Wrap Up:

Hologic, Inc., together with its subsidiaries, develops, manufactures, and distributes diagnostic and medical imaging systems for serving the healthcare needs of women. The company operates in four segments Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment offers breast imaging products, such as DirectRay Digital Detector; Selenia full field digital mammography system; Breast Tomosynthesis; screen-film mammography systems; SecurView Workstation; CAD Systems; Stereotactic Breast Biopsy Systems; breast biopsy products; MammoSite Radiation Therapy System; MammoPad Breast Cushion; and photoconductor coatings. The Diagnostic Products segment provides ThinPrep System, which is primarily used in cytology testing applications, such as cervical cancer screening; the Full Term Fetal Fibronectin Test for pre-term birth risk assessment; and invitro diagnostic devices, as well as focuses on genotyping products for Human Papillomavirus tests. The GYN Surgical Products segment?s offerings include NovaSure System, a minimally-invasive procedure that allows physicians to treat women suffering from excessive menstrual bleeding; and Adiana Complete Transcervical Sterilization System, a form of permanent female contraception intended as an alternative to tubal ligation. This segment?s products are in the process of seeking a pre-market approval from the U.S. Food and Drug Administration. The Skeletal Health Products segment provides a family of QDR dual energy x-ray bone densitometers; Sahara Clinical Bone Sonometers; mini C-arm imaging systems; and extremity MRI systems. It markets its products through a combination of direct sales and service force, and a network of independent distributors primarily in the United States, Europe, and Asia. The company was founded in 1985 and is headquartered in Bedford, Massachusetts.